A Pilot Study Assessing the Impact of rs174537 on Circulating Polyunsaturated Fatty Acids and the Inflammatory Response in Patients with Traumatic Brain Injury
- 1 September 2020
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Neurotrauma
- Vol. 37 (17), 1880-1891
- https://doi.org/10.1089/neu.2019.6734
Abstract
Traumatic brain injury (TBI) is a leading cause of death and disability in persons under age 45. The hallmark secondary injury profile after TBI involves dynamic interactions between inflammatory and metabolic pathways including fatty acids. Omega-3 polyunsaturated fatty acids (PUFAs) such as docosahexaenoic acid (DHA) have been shown to provide neuroprotective benefits by minimizing neuroinflammation in rodents. These effects have been less conclusive in humans, however. We postulate genetic variants influencing PUFA metabolism in humans could contribute to these disparate findings. Therefore, we sought to (1) characterize the circulating PUFA response and (2) evaluate the impact of rs174537 on inflammation after TBI. A prospective, single-center, observational pilot study was conducted to collect blood samples from Level-1 trauma patients (N = 130) on admission and 24 h post-admission. Plasma was used to quantify PUFA levels and inflammatory cytokines. Deoxyribonucleic acid was extracted and genotyped at rs174537. Associations between PUFAs and inflammatory cytokines were analyzed for all trauma cases and stratified by race (Caucasians only), TBI (TBI: N = 47; non-TBI = 83) and rs174537 genotype (GG: N = 33, GT/TT: N = 44). Patients with TBI had higher plasma DHA levels compared with non-TBI at 24 h post-injury (p = 0.013). The SNP rs174537 was associated with both PUFA levels and inflammatory cytokines (p < 0.05). Specifically, TBI patients with GG genotype exhibited the highest plasma levels of DHA (1.33%) and interleukin-8 (121.5 +/- 43.3 pg/mL), which were in turn associated with poorer outcomes. These data illustrate the impact of rs174537 on the post-TBI response. Further work is needed to ascertain how this genetic variant directly influences inflammation after trauma.Keywords
This publication has 62 references indexed in Scilit:
- Epoxyeicosanoids promote organ and tissue regenerationProceedings of the National Academy of Sciences of the United States of America, 2013
- Therapeutic use of omega-3 fatty acids in severe head traumaThe American Journal of Emergency Medicine, 2013
- Traumatic Brain Injury-Associated CoagulopathyJournal of Neurotrauma, 2012
- Differences in arachidonic acid levels and fatty acid desaturase (FADS) gene variants in African Americans and European Americans with diabetes or the metabolic syndromeBritish Journal of Nutrition, 2011
- Docosahexaenoic Acid (DHA): An Ancient Nutrient for the Modern Human BrainNutrients, 2011
- The impact of FADS genetic variants on ω6 polyunsaturated fatty acid metabolism in African AmericansBMC Genomic Data, 2011
- Diffuse Brain Injury Elevates Tonic Glutamate Levels and Potassium-Evoked Glutamate Release in Discrete Brain Regions at Two Days Post-Injury: An Enzyme-Based Microelectrode Array StudyJournal of Neurotrauma, 2010
- Omega-3 Fatty Acids and Inflammatory ProcessesNutrients, 2010
- Genome-Wide Association Study of Plasma Polyunsaturated Fatty Acids in the InCHIANTI StudyPLoS Genetics, 2009
- In Vivo and in Vitro Regulation of Syndecan 1 in Prostate Cells by n-3 Polyunsaturated Fatty AcidsPublished by Elsevier BV ,2008